- Home
- TPST vs MDCX Comparison
TPST vs MDCX Comparison
Compare TPST & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- MDCX
- Stock Information
- Founded
- TPST 2011
- MDCX 2008
- Country
- TPST United States
- MDCX Canada
- Employees
- TPST N/A
- MDCX N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- MDCX
- Sector
- TPST Health Care
- MDCX
- Exchange
- TPST Nasdaq
- MDCX Nasdaq
- Market Cap
- TPST 40.4M
- MDCX 33.8M
- IPO Year
- TPST N/A
- MDCX N/A
- Fundamental
- Price
- TPST $0.86
- MDCX $4.00
- Analyst Decision
- TPST Strong Buy
- MDCX Strong Buy
- Analyst Count
- TPST 3
- MDCX 1
- Target Price
- TPST $21.67
- MDCX $10.00
- AVG Volume (30 Days)
- TPST 877.6K
- MDCX 42.7K
- Earning Date
- TPST 03-18-2025
- MDCX 01-01-0001
- Dividend Yield
- TPST N/A
- MDCX N/A
- EPS Growth
- TPST N/A
- MDCX N/A
- EPS
- TPST N/A
- MDCX N/A
- Revenue
- TPST N/A
- MDCX N/A
- Revenue This Year
- TPST N/A
- MDCX N/A
- Revenue Next Year
- TPST N/A
- MDCX N/A
- P/E Ratio
- TPST N/A
- MDCX N/A
- Revenue Growth
- TPST N/A
- MDCX N/A
- 52 Week Low
- TPST $0.70
- MDCX $1.80
- 52 Week High
- TPST $6.00
- MDCX $4.39
- Technical
- Relative Strength Index (RSI)
- TPST 40.89
- MDCX N/A
- Support Level
- TPST $0.85
- MDCX N/A
- Resistance Level
- TPST $0.95
- MDCX N/A
- Average True Range (ATR)
- TPST 0.05
- MDCX 0.00
- MACD
- TPST -0.00
- MDCX 0.00
- Stochastic Oscillator
- TPST 9.45
- MDCX 0.00
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.